On-Treatment ALT Normalization Has No Statistical Significant Impact on Liver Stiffness Regression in Chinese Chronic Hepatitis B Patients with Advanced Fibrosis or Cirrhosis Receiving Tenofovir Disoproxil Fumarate Therapy | |
Wei, Lai; Shang, Jia; Xie, Qing; Jia, Zhansheng; Gao, Pujun; Shi, Junping; Chen, Xinyue; Wang, Jiefei; Xu, Min; Zhang, Liaoyun | |
刊名 | HEPATOLOGY |
2018 | |
卷号 | 68 |
ISSN号 | 0270-9139 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3535403 |
专题 | 吉林大学白求恩第一医院 |
推荐引用方式 GB/T 7714 | Wei, Lai,Shang, Jia,Xie, Qing,et al. On-Treatment ALT Normalization Has No Statistical Significant Impact on Liver Stiffness Regression in Chinese Chronic Hepatitis B Patients with Advanced Fibrosis or Cirrhosis Receiving Tenofovir Disoproxil Fumarate Therapy[J]. HEPATOLOGY,2018,68. |
APA | Wei, Lai.,Shang, Jia.,Xie, Qing.,Jia, Zhansheng.,Gao, Pujun.,...&Zhu, Mingfen.(2018).On-Treatment ALT Normalization Has No Statistical Significant Impact on Liver Stiffness Regression in Chinese Chronic Hepatitis B Patients with Advanced Fibrosis or Cirrhosis Receiving Tenofovir Disoproxil Fumarate Therapy.HEPATOLOGY,68. |
MLA | Wei, Lai,et al."On-Treatment ALT Normalization Has No Statistical Significant Impact on Liver Stiffness Regression in Chinese Chronic Hepatitis B Patients with Advanced Fibrosis or Cirrhosis Receiving Tenofovir Disoproxil Fumarate Therapy".HEPATOLOGY 68(2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论